Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.63% is 19% below its 3-year average of 3.24%, near the low end of its 3-year range (0.27%–156.36%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.13% below its 12-month average of 2.86%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.63%.
DEBT TO ASSETS RATIO
2.63%
DEBT TO ASSETS RATIO AVG TTM
2.86%
DEBT TO ASSETS RATIO AVG 3Y
2.31%
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.13%
CURRENT VS 3Y AVG
+13.55%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+2817.49%
vs the sector median at left
Contineum Therapeutics, Inc.
Market Cap
$475.91M
Debt to Assets Ratio
2.63%
TTM Avg
2.86%
3Y Avg
2.31%
5Y Avg
N/A
Market Cap
$472.23M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$469.12M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$483.54M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$465.75M
Debt to Assets Ratio
0.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | $475.91M | 2.63% | 2.86% | 2.31% | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | 0.00% | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $471.65M | 0.01% | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $471.57M | 0.37% | N/A | N/A | N/A |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | 0.29% | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 0.02% | N/A | N/A | N/A |
| Kamada Ltd. (KMDA)vs › | $467.90M | 0.03% | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $486.01M | 0.66% | N/A | N/A | N/A |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | 0.40% | N/A | N/A | N/A |
| Oculis Holding AG (OCS)vs › | $498.52M | 0.01% | N/A | N/A | N/A |
Debt/Assets
2.6%
Debt/Equity
0.03
Current Ratio
37.17
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.63% |
| 2026-03-31 | 2.66% |
| 2025-12-31 | 2.98% |
| 2025-09-30 | 2.88% |
| 2025-06-30 | 3.14% |
| 2025-03-31 | 3.03% |
| 2024-12-31 | 2.94% |
| 2024-09-30 | 0.28% |
| 2024-06-30 | 0.27% |
| 2024-03-31 | 156.36% |
| 2023-12-31 | 148.17% |
| 2023-09-30 | 139.34% |
| 2022-12-31 | 11.55% |
